SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Murgatroyd, L.B.
Right arrow Articles by Middleton, B.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murgatroyd, L.B.
Right arrow Articles by Middleton, B.J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

1H-NMR Spectroscopy as a Means of Monitoring Nephrotoxicity as Exemplified by Studies with Cephaloridine

L.B. Murgatroyd

ICI Pharmaceuticals Safety of Medicines Department, Mereside. Alderley Park, Macclesfield, SK10 4TG, UK

R.J. Pickford

ICI Pharmaceuticals Safety of Medicines Department, Mereside. Alderley Park, Macclesfield, SK10 4TG, UK

I.K. Smith

ICI Pharmaceuticals Safety of Medicines Department, Mereside. Alderley Park, Macclesfield, SK10 4TG, UK

I.D. Wilson

ICI Pharmaceuticals Safety of Medicines Department, Mereside. Alderley Park, Macclesfield, SK10 4TG, UK

B.J. Middleton

ICI Pharmaceuticals Safety of Medicines Department, Mereside. Alderley Park, Macclesfield, SK10 4TG, UK

1 Male albino rats were dosed intravenously with either 0.9% saline or cephaloridine in saline at doses of 650, 750 or 950 mg kg-1 d-1 for 7 d.

2 Urine analysis on day 3, after two doses of cephaloridine showed dose-related increases in glucose, total protein, N-acetyl β-D-glucosaminidase, y-glutamyltranspeptidase, alkaline phosphatase and lactate dehydrogenase. 1H-NMR spectroscopy showed corresponding disturbed profiles of products of intermediary metabolism indicative of a disruption of renal function.

3 By day 6, after five doses of cephaloridine, analysis by both 1H-NMR and conventional methods showed that all indices had returned to normal. 1H-NMR was demonstrated to provide useful complementary information to conventional techniques on the time course of the onset of the nephrotoxicity and the recovery phase, and was at least as sensitive as conventional urine analysis.

Human & Experimental Toxicology, Vol. 11, No. 1, 35-41 (1992)
DOI: 10.1177/096032719201100105


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
P. Harvey, G. Healing, I. Major, M. McFarlane, K. Purdy, O. Olatunde, M. Garcia Conesa, D. Everett, and A. Cockburn
Glucocorticoid amelioration of nephrotoxicity: a study of cephaloridine- methylprednisolone interaction in the rat
Human and Experimental Toxicology, July 1, 1995; 14(7): 554 - 561.
[Abstract] [PDF]



Advertisement